OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IONS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Ionis Pharmaceuticals (IONS) Earnings Date & Reports

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IONS is expected to report earnings to fall 274.29% to -122 cents per share on October 30

Ionis Pharmaceuticals IONS Stock Earnings Reports

Q3'25

Est.

$-1.22

Q2'25

Beat

by $0.94

Q1'25

Beat

by $0.15

Q4'24

Beat

by $0.45

Q3'24

Beat

by $0.17

The last earnings report on July 30 showed earnings per share of 69 cents, beating the estimate of -23 cents. With 2.58M shares outstanding, the current market capitalization sits at 11.02B.

View a ticker or compare two or three

Compare

IONS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IONS
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IONS showed earnings on July 30, 2025. You can read more about the earnings report here.

View AI-Driven Trading for IONS

A.I. Advisor

published General Information

General Information

a developer of antisense drugs

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2855 Gazelle Court

Phone

+1 760 931-9200

Employees

927

Web

https://www.ionispharma.com